Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-150,600
Closed -$9.3M – 576
2023
Q3
$9.3M Buy
+150,600
New +$9.53M 0.17% 61
2022
Q4
– Sell
-110,193
Closed -$9.19M – 806
2022
Q3
$9.19M Buy
+110,193
New +$9.48M 0.1% 120
2021
Q3
– Sell
-80,000
Closed -$4.85M – 968
2021
Q2
$4.85M Buy
+80,000
New +$4.73M 0.04% 274

Other funds holding NTR

UBS O'Connor's NTR Position: Q4 2023 in Review

UBS O'Connor sold out of Nutrien (NTR) in Q4 2023, closing a stake of 150,600 shares — an estimated $9.3M sold.

UBS O'Connor first reported a position in NTR in Q2 2021 and held it in 3 quarters. The position peaked at $9.3M in Q3 2023. 640 funds tracked by Wall St. Rank hold NTR as of Q4 2023.

  • UBS O'Connor reported no remaining Nutrien position as of Q4 2023 after selling out during the quarter.
  • UBS O'Connor sold 150,600 Nutrien shares in Q4 2023, an estimated $9.3M.
  • UBS O'Connor first reported a position in Nutrien in Q2 2021 and held it in 3 quarters.
  • UBS O'Connor's Nutrien position peaked at $9.3M in Q3 2023.
  • 640 funds tracked by Wall St. Rank held Nutrien as of Q4 2023.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.